batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Monjuvi hits in the front line, but what about Revlimid? 5 January 2026 Datroway’s Tropion-Lung01 do-over? 2 January 2026 No magical surprise for Astra in ATR inhibition 22 December 2025 Compugen makes money from TIGIT 22 December 2025 Circle’s next cycle 19 December 2025 PI3K conjugates enter the clinic 17 December 2025 Padcev and Keytruda prevail again in early bladder cancer 17 December 2025 Genfleet targets relapsed pancreatic cancer 11 December 2025 Load More